Guanylyl Cyclases

Handbook of Cell Signaling, Second Edition

Volumn 2, Issue , 2009, Pages 1399-1407

  Potter, Lincoln R ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882924405     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-374145-5.00172-8     Document Type: Chapter

References (118)

1. DF A shman, R Lipton, MM Melicow and TD Price (1963) Isolation of adenosine 3′,5′-monophosphate and guanosine 3′,5′-monophosphate from rat urine. Biochem Biophys Res Commun 11 330-334.
2. JG Hardman and EW Sutherland (1969) Guanyl cyclase, an enzyme catalyzing the formation of guanosine 3′,5′-monophosphate from guanosine trihosphate. J Biol Chem 244 6363-6370.
3. G Schultz, E Bohme and K Munske (1969) Guanyl cyclase. Determination of enzyme activity. Life Sci 8 1323-1332.
4. AA White and GD Aurbach (1969) Detection of guanyl cyclase in mammalian tissues. Biochim Biophys Acta 191 686-697.
5. TD Chrisman, DL Garbers, MA Parks and JG Hardman (1975) Characterization of particulate and soluble guanylate cyclases from rat lung. J Biol Chem 250 374-381.
6. H Kimura and F Murad (1974) Evidence for two different forms of guanylate cyclase in rat heart. J Biol Chem 249 6910-6916.
7. Y Liu, AE Ruoho, VD Rao and JH Hurley (1997) Catalytic mechanism of the adenylyl and guanylyl cyclases: modeling and mutational analysis. Proc Natl Acad Sci USA 94 13,414-13,419.
8. DK Thompson and DL Garbers (1995) Dominant negative mutations of the guanylyl cyclase-A receptor. Extracellular domain deletion and catalytic domain point mutations. J Biol Chem 270 425-430.
9. RK Sunahara, A Beuve, JJ Tesmer, SR Sprang, DL Garbers and AG Gilman (1998) Exchange of substrate and inhibitor specificities between adenylyl and guanylyl cyclases. J Biol Chem 273 16,332-16,338.
10. CL Tucker, JH Hurley, TR Miller and JB Hurley (1998) Two amino acid substitutions convert a guanylyl cyclase, RetGC-1, into an adenylyl cyclase. Proc Natl Acad Sci USA 95 5993-5997.
11. N Chen, TW Harris, I Antoshechkin, et al. (2005) WormBase: a comprehensive data resource for Caenorhabditis biology and genomics. Nucleic Acids Res 33 D383-D389.
12. JU Linder and JE Schultz (2002) Guanylyl cyclases in unicellular organisms. Mol Cell Biochem 230 149-158.
13. JA Ochoa De Alda, G Ajlani and J Houmard (2000) Synechocystis strain PCC 6803 cya2, a prokaryotic gene that encodes a guanylyl cyclase. J Bacteriol 182 3839-3842.
14. DA Fitzpatrick, DM O’Halloran and AM Burnell (2006) Multiple lineage specific expansions within the guanylyl cyclase gene family. BMC Evol Biol 6 26.
15. RF Furchgott and JV Zawadzki (1980) The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288 373-376.
16. PL Huang, Z Huang, H Mashimo, et al. (1995) Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 377 239-242.
17. EG Shesely, N Maeda, HS Kim, et al. (1996) Elevated blood pressures in mice lacking endothelial nitric oxide synthase. Proc Natl Acad Sci USA 93 13,176-13,181.
18. PL Huang, TM Dawson, DS Bredt, SH Snyder and MC Fishman (1993) Targeted disruption of the neuronal nitric oxide synthase gene. Cell 75 1273-1286.
19. RJ Nelson, GE Demas, PL Huang, et al. (1995) Behavioural abnormalities in male mice lacking neuronal nitric oxide synthase. Nature 378 383-386.
20. JD MacMicking, C Nathan, G Hom, et al. (1995) Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 81 641-650.
21. XQ Wei, IG Charles, A Smith, et al. (1995) Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 375 408-411.
22. PS Yuen, LR Potter and DL Garbers (1990) A new form of guanylyl cyclase is preferentially expressed in rat kidney. Biochemistry 29 10,872-10,878.
23. M Koglin, K Vehse, L Budaeus, H Scholz and S Behrends (2001) Nitric oxide activates the beta 2 subunit of soluble guanylyl cyclase in the absence of a second subunit. J Biol Chem 276 30,737-30,743.
24. G Giuili, U Scholl, F Bulle and G Guellaen (1992) Molecular cloning of the cDNAs coding for the two subunits of soluble guanylyl cyclase from human brain. FEBS Letts 304 83-88.
25. C Harteneck, B Wedel, D Koesling, J Malkewitz, E Bohme and G Schultz (1991) Molecular cloning and expression of a new alpha-subunit of soluble guanylyl cyclase. Interchangeability of the alpha-subunits of the enzyme. FEBS Letts 292 217-222.
26. E Mergia, A Friebe, O Dangel, M Russwurm and D Koesling (2006) Spare guanylyl cyclase NO receptors ensure high NO sensitivity in the vascular system. J Clin Invest 116 1731-1737.
27. B Wedel, P Humbert, C Harteneck, et al. (1994) Mutation of His-105 in the beta 1 subunit yields a nitric oxide-insensitive form of soluble guanylyl cyclase. Proc Natl Acad Sci USA 91 2592-2596.
28. A Friebe, E Mergia, O Dangel, A Lange and D Koesling (2007) Fatal gastrointestinal obstruction and hypertension in mice lacking nitric oxide-sensitive guanylyl cyclase. Proc Natl Acad Sci USA 104 7699-7704.
29. A Pfeifer, P Klatt, S Massberg, et al. (1998) Defective smooth muscle regulation in cGMP kinase I-deficient mice. EMBO J 17 3045-3051.
30. S Suga, K Nakao, K Hosoda, et al. (1992) Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide. Endocrinology 130 229-239.
31. SW John, JH Krege, PM Oliver, et al. (1995) Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension. Science 267 679-681. (published erratum in Science 267:1753)
32. SW John, AT Veress, U Honrath, et al. (1996) Blood pressure and fluid-electrolyte balance in mice with reduced or absent ANP. Am J Physiol 271 R109-R114.
33. N Tamura, Y Ogawa, H Chusho, et al. (2000) Cardiac fibrosis in mice lacking brain natriuretic peptide. Proc Natl Acad Sci USA 97 4239-4244.
34. PM Bryan, D Smirnov, A Smolenski, et al. (2006) A sensitive method for determining the phosphorylation status of natriuretic peptide receptors: cGK-Ialpha does not regulate NPR-A. Biochemistry 45 1295-1303.
35. LR Potter, S Abbey-Hosch and DM Dickey (2006) Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions. Endocr Rev 27 47-72.
36. LR Potter and T Hunter (2001) Guanylyl cyclase-linked natriuretic peptide receptors: structure and regulation. J Biol Chem 276 6057-6060.
37. H Ogawa, Y Qiu, CM Ogata and KS Misono (2004) Crystal structure of hormone-bound atrial natriuretic peptide receptor extracellular domain: rotation mechanism for transmembrane signal transduction. J Biol Chem 279 28,625-28,631.
38. LR Potter and T Hunter (1998) Phosphorylation of the kinase homology domain is essential for activation of the A-type natriuretic peptide receptor. Mol Cell Biol 18 2164-2172.
39. LR Potter and DL Garbers (1992) Dephosphorylation of the guanylyl cyclase-A receptor causes desensitization. J Biol Chem 267 14,531-14,534.
40. M Chinkers, S Singh and DL Garbers (1991) Adenine nucleotides are required for activation of rat atrial natriuretic peptide receptor/guanylyl cyclase expressed in a baculovirus system. J Biol Chem 266 4088-4093.
41. H Kurose, T Inagami and M Ui (1987) Participation of adenosine 5′-triphosphate in the activation of membrane-bound guanylate cyclase by the atrial natriuretic factor. FEBS Letts 219 375-379.
42. LK Antos, SE Abbey-Hosch, DR Flora and LR Potter (2005) ATP-independent activation of natriuretic peptide receptors. J Biol Chem 280 26,928-26,932.
43. LK Antos and LR Potter (2007) Adenine nucleotides decrease the apparent Km of endogenous natriuretic peptide receptors for GTP. Am J Physiol Endocrinol Metab 293 E1756-E1763.
44. MJ Lopez, SK Wong, I Kishimoto, et al. (1995) Salt-resistant hypertension in mice lacking the guanylyl cyclase-A receptor for atrial natriuretic peptide. Nature 378 65-68.
45. PM Oliver, JE Fox, R Kim, et al. (1997) Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A. Proc Natl Acad Sci USA 94 14,730-14,735.
46. KJ Koller, DG Lowe, GL Bennett, et al. (1991) Selective activation of the B natriuretic peptide receptor by C-type natriuretic peptide (CNP). Science 252 120-123.
47. R Bocciardi, R Giorda, J Buttgereit, et al. (2007) Overexpression of the C-type natriuretic peptide (CNP) is associated with overgrowth and bone anomalies in an individual with balanced t(2;7) translocation. Hum Mutat 28 724-731.
48. A Moncla, C Missirian, P Cacciagli, et al. (2007) A cluster of translocation breakpoints in 2q37 is associated with overexpression of NPPC in patients with a similar overgrowth phenotype. Hum Mutat 12 1183-1188.
49. S Schulz, S Singh, RA Bellet, et al. (1989) The primary structure of a plasma membrane guanylate cyclase demonstrates diversity within this new receptor family. Cell 58 1155-1162.
50. M Nagase, T Katafuchi, S Hirose and T Fujita (1997) Tissue distribution and localization of natriuretic peptide receptor subtypes in stroke-prone spontaneously hypertensive rats. J Hypertens 15 1235-1243.
51. TD Chrisman, S Schulz, LR Potter and DL Garbers (1993) Seminal plasma factors that cause large elevations in cellular cyclic GMP are C-type natriuretic peptides. J Biol Chem 268 3698-3703.
52. R Potthast, SE Abbey-Hosch, LK Antos, JS Marchant, M Kuhn and LR Potter (2004) Calcium-dependent dephosphorylation mediates the hyperosmotic and lysophosphatidic acid-dependent inhibition of natriuretic peptide receptor-B/guanylyl cyclase-B. J Biol Chem 279 48,513-48,519.
53. LR Potter and T Hunter (2000) Activation of PKC stimulates the dephosphorylation of natriuretic peptide receptor-B at a single serine residue: a possible mechanism of heterologous desensitization. J Biol Chem 275 31,099-31,106.
54. LR Potter (1998) Phosphorylation-dependent regulation of the guanylyl cyclase-linked natriuretic peptide receptor B: dephosphorylation is a mechanism of desensitization. Biochemistry 37 2422-2429.
55. N Tamura, LK Doolittle, RE Hammer, JM Shelton, JA Richardson and DL Garbers (2004) Critical roles of the guanylyl cyclase B receptor in endochondral ossification and development of female reproductive organs. Proc Natl Acad Sci USA 101 17,300-17,305.
56. T Tsuji and T Kunieda (2005) A loss-of-function mutation in natriuretic peptide receptor 2 (Npr2) gene is responsible for disproportionate dwarfism in cn/cn mouse. J Biol Chem 280 14,288-14,292.
57. CF Bartels, H Bukulmez, P Padayatti, et al. (2004) Mutations in the transmembrane natriuretic peptide receptor NPR-B impair skeletal growth and cause acromesomelic dysplasia, type Maroteaux. Am J Hum Genet 75 27-34.
58. RC Olney, H Bukulmez, CF Bartels, et al. (2006) Heterozygous mutations in natriuretic peptide receptor-B (NPR2) are associated with short stature. J Clin Endocrinol Metab 91 1229-1232.
59. DM Dickey, DR Flora, PM Bryan, X Xu, Y Chen and LR Potter (2007) Differential regulation of membrane guanylyl cyclases in congestive heart failure: natriuretic peptide receptor (NPR)-B, Not NPR-A, is the predominant natriuretic peptide receptor in the failing heart. Endocrinology 148 3518-3522.
60. TO Peltonen, P Taskinen, Y Soini, et al. (2007) Distinct downregulation of C-type natriuretic peptide system in human aortic valve stenosis. Circulation 116 1283-1289.
61. H Schmidt, A Stonkute, R Juttner, et al. (2007) The receptor guanylyl cyclase Npr2 is essential for sensory axon bifurcation within the spinal cord. J Cell Biol 179 331-340.
62. LR Potter (2005) Domain analysis of human transmembrane guanylyl cyclase receptors: implications for regulation. Front Biosci 10 1205-1220.
63. P Moffatt, G Thomas, K Sellin, et al. (2007) Osteocrin is a specific ligand of the natriuretic Peptide clearance receptor that modulates bone growth. J Biol Chem 282 36,454-36,462.
64. G Thomas, P Moffatt, P Salois, et al. (2003) Osteocrin, a novel bone-specific secreted protein that modulates the osteoblast phenotype. J Biol Chem 278 50,563-50,571.
65. JT Stults, KL O’Connell, C Garcia, et al. (1994) The disulfide linkages and glycosylation sites of the human natriuretic peptide receptor-C homodimer. Biochemistry 33 11,372-11,381.
66. DR Nussenzveig, JA Lewicki and T Maack (1990) Cellular mechanisms of the clearance function of type C receptors of atrial natriuretic factor. J Biol Chem 265 20,952-20,958.
67. D Cohen, GY Koh, LN Nikonova, JG Porter and T Maack (1996) Molecular determinants of the clearance function of type C receptors of natriuretic peptides. J Biol Chem 271 9863-9869.
68. D Fan, PM Bryan, LK Antos, RJ Potthast and LR Potter (2005) Down-regulation does not mediate natriuretic peptide-dependent desensitization of natriuretic peptide receptor (NPR)-A or NPR-B: guanylyl cyclase-linked natriuretic peptide receptors do not internalize. Mol Pharmacol 67 174-183.
69. J Jaubert, F Jaubert, N Martin, et al. (1999) Three new allelic mouse mutations that cause skeletal overgrowth involve the natriuretic peptide receptor C gene (Npr3). Proc Natl Acad Sci USA 96 10,278-10,283.
70. N Matsukawa, WJ Grzesik, N Takahashi, et al. (1999) The natriuretic peptide clearance receptor locally modulates the physiological effects of the natriuretic peptide system. Proc Natl Acad Sci USA 96 7403-7408.
71. MB Anand-Srivastava and GJ Trachte (1993) Atrial natriuretic factor receptors and signal transduction mechanisms. Pharmacol Rev 45 455-497.
72. MG Currie, KF Fok, J Kato, et al. (1992) Guanylin: an endogenous activator of intestinal guanylate cyclase. Proc Natl Acad Sci USA 89 947-951.
73. FK Hamra, LR Forte, SL Eber, et al. (1993) Uroguanylin: structure and activity of a second endogenous peptide that stimulates intestinal guanylate cyclase. Proc Natl Acad Sci USA 90 10,464-10,468.
74. KA Steinbrecher, SA Wowk, JA Rudolph, DP Witte and MB Cohen (2002) Targeted inactivation of the mouse guanylin gene results in altered dynamics of colonic epithelial proliferation. Am J Pathol 161 2169-2178.
75. JN Lorenz, M Nieman, J Sabo, et al. (2003) Uroguanylin knockout mice have increased blood pressure and impaired natriuretic response to enteral NaCl load. J Clin Invest 112 1244-1254.
76. Y Ghanekar, A Chandrashaker, U Tatu and SS Visweswariah (2004) Glycosylation of the receptor guanylate cyclase C: role in ligand binding and catalytic activity. Biochem J 379 653-663.
77. M Hasegawa, Y Hidaka, A Wada, T Hirayama and Y Shimonishi (1999) The relevance of N-linked glycosylation to the binding of a ligand to guanylate cyclase C. Eur J Biochem 263 338-346.
78. AB Vaandrager, S Schulz, HR De Jonge and DL Garbers (1993) Guanylyl cyclase C is an N-linked glycoprotein receptor that accounts for multiple heat-stable enterotoxin-binding proteins in the intestine. J Biol Chem 268 2174-2179.
79. M Hasegawa, Y Matsumoto-Ishikawa, A Hijikata, Y Hidaka, M Go and Y Shimonishi (2005) Disulfide linkages and a three-dimensional structure model of the extracellular ligand-binding domain of guanylyl cyclase C. Protein J 24 315-325.
80. AB Vaandrager, E van der Wiel and HR de Jonge (1993) Heat-stable enterotoxin activation of immunopurified guanylyl cyclase C. Modulation by adenine nucleotides. J Biol Chem 268 19,598-19,603.
81. AB Vaandrager, E van der Wiel, ML Hom, LH Luthjens and HR de Jonge (1994) Heat-stable enterotoxin receptor/guanylyl cyclase C is an oligomer consisting of functionally distinct subunits, which are non-covalently linked in the intestine. J Biol Chem 269 16,409-16,415.
82. R Bhandari, N Srinivasan, M Mahaboobi, Y Ghanekar, K Suguna and SS Visweswariah (2001) Functional inactivation of the human guanylyl cyclase C receptor: modeling and mutation of the protein kinase-like domain. Biochemistry 40 9196-9206.
83. H Gazzano, HI Wu and SA Waldman (1991) Activation of particulate guanylate cyclase by Escherichia coli heat-stable enterotoxin is regulated by adenine nucleotides. Infect Immun 59 1552-1557.
84. JK Crane and KL Shanks (1996) Phosphorylation and activation of the intestinal guanylyl cyclase receptor for Escherichia coli heat-stable toxin by protein kinase C. Mol Cell Biochem 165 111-120.
85. P Li, JE Lin, I Chervoneva, S Schulz, SA Waldman and GM Pitari (2007) Homeostatic control of the crypt-villus axis by the bacterial enterotoxin receptor guanylyl cyclase C restricts the proliferating compartment in intestine. Am J Pathol 171 1847-1858.
86. EA Mann, ML Jump, J Wu, E Yee and RA Giannella (1997) Mice lacking the guanylyl cyclase C receptor are resistant to STa-induced intestinal secretion. Biochem Biophys Res Commun 239 463-466.
87. S Schulz, MJ Lopez, M Kuhn and DL Garbers (1997) Disruption of the guanylyl cyclase-C gene leads to a paradoxical phenotype of viable but heat-stable enterotoxin-resistant mice. J Clin Invest 100 1590-1595.
88. SL Carrithers, SJ Parkinson, S Goldstein, P Park, DC Robertson and SA Waldman (1994) Escherichia coli heat-stable toxin receptors in human colonic tumors. Gastroenterology 107 1653-1661.
89. GM Pitari, MD Di Guglielmo, J Park, S Schulz and SA Waldman (2001) Guanylyl cyclase C agonists regulate progression through the cell cycle of human colon carcinoma cells. Proc Natl Acad Sci USA 98 7846-7851.
90. GM Pitari, LV Zingman, DM Hodgson, et al. (2003) Bacterial enterotoxins are associated with resistance to colon cancer. Proc Natl Acad Sci USA 100 2695-2699.
91. K Shailubhai, HH Yu, K Karunanandaa, et al. (2000) Uroguanylin treatment suppresses polyp formation in the Apc(Min/+) mouse and induces apoptosis in human colon adenocarcinoma cells via cyclic GMP. Cancer Res 60 5151-5157.
92. HJ Fulle, R Vassar, DC Foster, RB Yang, R Axel and DL Garbers (1995) A receptor guanylyl cyclase expressed specifically in olfactory sensory neurons. Proc Natl Acad Sci USA 92 3571-3575.
93. DM Juilfs, HJ Fulle, AZ Zhao, MD Houslay, DL Garbers and JA Beavo (1997) A subset of olfactory neurons that selectively express cGMP-stimulated phosphodiesterase (PDE2) and guanylyl cyclase-D define a unique olfactory signal transduction pathway. Proc Natl Acad Sci USA 94 3388-3395.
94. MR Meyer, A Angele, E Kremmer, UB Kaupp and F Muller (2000) A cGMP-signaling pathway in a subset of olfactory sensory neurons. Proc Natl Acad Sci USA 97 10,595-10,600.
95. T Leinders-Zufall, RE Cockerham, S Michalakis, et al. (2007) Contribution of the receptor guanylyl cyclase GC-D to chemosensory function in the olfactory epithelium. Proc Natl Acad Sci USA 104 14,507-14,512.
96. JM Young, H Waters, C Dong, HJ Fulle and ER Liman (2007) Degeneration of the olfactory guanylyl cyclase D gene during primate evolution. PLoS ONE 2 e884.
97. RN Lolley and E Racz (1982) Calcium modulation of cyclic GMP synthesis in rat visual cells. Vision Res 22 1481-1486.
98. KW Koch and L Stryer (1988) Highly cooperative feedback control of retinal rod guanylate cyclase by calcium ions. Nature 334 64-66.
99. DG Lowe, AM Dizhoor, K Liu, et al. (1995) Cloning and expression of a second photoreceptor-specific membrane retina guanylyl cyclase (RetGC), RetGC-2. Proc Natl Acad Sci USA 92 5535-5539.
100. AW Shyjan, FJ de Sauvage, NA Gillett, DV Goeddel and DG Lowe (1992) Molecular cloning of a retina-specific membrane guanylyl cyclase. Neuron 9 727-737.
101. RB Yang, DC Foster, DL Garbers and HJ Fulle (1995) Two membrane forms of guanylyl cyclase found in the eye. Proc Natl Acad Sci USA 92 602-606.
102. AM Dizhoor, DG Lowe, EV Olshevskaya, RP Laura and JB Hurley (1994) The human photoreceptor membrane guanylyl cyclase, RetGC, is present in outer segments and is regulated by calcium and a soluble activator. Neuron 12 1345-1352.
103. WA Gorczyca, MP Gray-Keller, PB Detwiler and K Palczewski (1994) Purification and physiological evaluation of a guanylate cyclase activating protein from retinal rods. Proc Natl Acad Sci USA 91 4014-4018.
104. K Palczewski, I Subbaraya, WA Gorczyca, et al. (1994) Molecular cloning and characterization of retinal photoreceptor guanylyl cyclase-activating protein. Neuron 13 395-404.
105. AM Dizhoor, EV Olshevskaya, WJ Henzel, et al. (1995) Cloning, sequencing, and expression of a 24-kDa Ca(2+)-binding protein activating photoreceptor guanylyl cyclase. J Biol Chem 270 25,200-25,206.
106. RB Yang, SW Robinson, WH Xiong, KW Yau, DG Birch and DL Garbers (1999) Disruption of a retinal guanylyl cyclase gene leads to cone-specific dystrophy and paradoxical rod behavior. J Neurosci 19 5889-5897.
107. CL Tucker, V Ramamurthy, AL Pina, et al. (2004) Functional analyses of mutant recessive GUCY2D alleles identified in Leber congenital amaurosis patients: protein domain comparisons and dominant negative effects. Mol Vis 10 297-303.
108. S Hanein, I Perrault, S Gerber, et al. (2004) Leber congenital amaurosis: comprehensive survey of the genetic heterogeneity, refinement of the clinical definition, and genotype-phenotype correlations as a strategy for molecular diagnosis. Hum Mutat 23 306-317.
109. W Baehr, S Karan, T Maeda, et al. (2007) The function of guanylate cyclase 1 and guanylate cyclase 2 in rod and cone photoreceptors. J Biol Chem 282 8837-8847.
110. A Mendez, ME Burns, I Sokal, et al. (2001) Role of guanylate cyclase-activating proteins (GCAPs) in setting the flash sensitivity of rod photoreceptors. Proc Natl Acad Sci USA 98 9948-9953.
111. ME Pennesi, KA Howes, W Baehr and SM Wu (2003) Guanylate cyclase-activating protein (GCAP) 1 rescues cone recovery kinetics in GCAP1/GCAP2 knockout mice. Proc Natl Acad Sci USA 100 6783-6788.
112. KA Howes, ME Pennesi, I Sokal, et al. (2002) GCAP1 rescues rod photoreceptor response in GCAP1/GCAP2 knockout mice. EMBO J 21 1545-1554.
113. K Palczewski, I Sokal and W Baehr (2004) Guanylate cyclase-activating proteins: structure, function, and diversity. Biochem Biophys Res Commun 322 1123-1130.
114. S Schulz, CK Green, PS Yuen and DL Garbers (1990) Guanylyl cyclase is a heat-stable enterotoxin receptor. Cell 63 941-948.
115. S Schulz, BJ Wedel, A Matthews and DL Garbers (1998) The cloning and expression of a new guanylyl cyclase orphan receptor. J Biol Chem 273 1032-1037.
116. M Kuhn, CK Ng, YH Su, et al. (2004) Identification of an orphan guanylate cyclase receptor selectively expressed in mouse testis. Biochem J 379 385-393.
117. H Lin, CF Cheng, HH Hou, et al. (2008) Disruption of guanylyl cyclase-G protects against acute renal injury. J Am Soc Nephrol 19 339-348.
118. G Manning, DB Whyte, R Martinez, T Hunter and S Sudarsanam (2002) The protein kinase complement of the human genome. Science 298 1912-1934.